Domenica Lorusso

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 49

Top Topics

Endometrial Cancer

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of gynecologic oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli, Giorgio Valabrega, Nicoletta Colombo, Carmela Pisano, Chiara Cassani, Germana Tognon, Stefano Tamberi, Giorgia Mangili, Serafina Mammoliti, Ugo De Giorgi, Filippo Greco, Anna Maria Mosconi, Enrico Breda, Grazia Artioli, Claudia Andreetta, Claudia Casanova, Rita Ceccherini, Antonio Frassoldati, Vanda Salutari, Serena Giolitto, Giovanni Scambia
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Aleksandra Helena Symonides, Houssein El Hajj, Nicolò Bizzarri, Esra Bilir, Tibor Andrea Zwimpfer, Aleksandra Natalia Strojna, Khayal Gasimli, Martina Aida Angeles, Valentina Ghirardi, Hadi Erfani, Tanja Nikolova, Charalampos Theofanakis, Richard Tóth, Jordi Ponce Sebastià, Luis Chiva de Agustín, Domenica Lorusso
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (9) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli, Giorgio Valabrega, Nicoletta Colombo, Carmela Pisano, Chiara Cassani, Germana Tognon, Stefano Tamberi, Giorgia Mangili, Serafina Mammoliti, Ugo De Giorgi, Filippo Greco, Anna Maria Mosconi, Enrico Breda, Grazia Artioli, Claudia Andreetta, Claudia Casanova, Rita Ceccherini, Antonio Frassoldati, Vanda Salutari, Serena Giolitto, Giovanni Scambia
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, Cumhur Tekin, Stephen M Keefe, Domenica Lorusso
Reply to P.-H. Luo et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Matteo Bruno, Adriana Ionelia Apostol, Serena Maria Boccia, Carolina Maria Sassu, Sara Lardino, Camilla Culcasi, Domenica Lorusso, Giovanni Scambia, Anna Fagotti, Claudia Marchetti
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Giovanni Fucà, Ilaria Sabatucci, Mariachiara Paderno, Domenica Lorusso
The clinical landscape of antibody-drug conjugates in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, Cumhur Tekin, Stephen M Keefe, Domenica Lorusso
Reply to P.-H. Luo et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aleksandra Helena Symonides, Houssein El Hajj, Nicolò Bizzarri, Esra Bilir, Tibor Andrea Zwimpfer, Aleksandra Natalia Strojna, Khayal Gasimli, Martina Aida Angeles, Valentina Ghirardi, Hadi Erfani, Tanja Nikolova, Charalampos Theofanakis, Richard Tóth, Jordi Ponce Sebastià, Luis Chiva de Agustín, Domenica Lorusso
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Giorgia Dinoi, Domenica Lorusso, Eleonora La Fera, Stefano Restaino, Pia Clara Pafundi, Alessandro Gioè, Laura Naccarato, Emilia Palmieri, Lucia Musacchio, Ettore Di Stefano, Vincenzo Tarantino, Giovanni Scambia, Francesco Fanfani
Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli, Giorgio Valabrega, Nicoletta Colombo, Carmela Pisano, Chiara Cassani, Germana Tognon, Stefano Tamberi, Giorgia Mangili, Serafina Mammoliti, Ugo De Giorgi, Filippo Greco, Anna Maria Mosconi, Enrico Breda, Grazia Artioli, Claudia Andreetta, Claudia Casanova, Rita Ceccherini, Antonio Frassoldati, Vanda Salutari, Serena Giolitto, Giovanni Scambia
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Vanda Salutari, Viola Ghizzoni, Maria Vittoria Carbone, Elena Giudice, Serena Cappuccio, Francesco Fanfani, Giovanni Scambia, Domenica Lorusso
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, Coraline Dubot, M Valeria Caceres, Kosei Hasegawa, Ronnie Shapira-Frommer, Pamela Salman, Eduardo Yañez, Mahmut Gümüş, Mivael Olivera, Vanessa Samouëlian, Vincent Castonguay, Alexander Arkhipov, Cumhur Tekin, Kan Li, Stephen M Keefe, Domenica Lorusso, null null
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, Bradley J Monk, Helen Mackay, Alessandro D Santin, David Scott Miller, Richard G Moore, Sally Baron-Hay, Isabelle L Ray-Coquard, Kimio Ushijma, Kan Yonemori, Yong Man Kim, Eva M Guerra Alia, Ulus A Sanli, Steven Bird, Robert Orlowski, Jodi-Ann Mckenzie, Chinyere E Okpara, Gianmaria Barresi, Domenica Lorusso
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lara Paracchini, Laura Mannarino, Chiara Romualdi, Riccardo Zadro, Luca Beltrame, Ilaria Fuso Nerini, Paolo Zola, Maria E Laudani, Eva Pagano, Livia Giordano, Robert Fruscio, Fabio Landoni, Silvia Franceschi, Maria L Dalessandro, Vincenzo Canzonieri, Luca Bocciolone, Domenica Lorusso, Cristina Bosetti, Francesco Raspagliesi, Isabella M G Garassino, null null, Maurizio D'Incalci, Sergio Marchini
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer. Science translational medicine 15 (725) (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Nicoletta Colombo, Toon Van Gorp, Ursula A Matulonis, Ana Oaknin, Rachel N Grisham, Gini F Fleming, Alexander B Olawaiye, Dorothy D Nguyen, Andrew E Greenstein, Joseph M Custodio, Hristina I Pashova, Iulia C Tudor, Domenica Lorusso
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Elena Giudice, Mansoor Raza Mirza, Domenica Lorusso
Advances in the Management of Recurrent Cervical Cancer: State of the Art and Future Perspectives. Current oncology reports (2023)
Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, Anneke M Westermann, Domenica Lorusso, Sharad Ghamande, Dearbhaile C Collins, Susana Banerjee, Cara A Mathews, Christine Gennigens, David Cibula, Krishnansu S Tewari, Kristine Madsen, Fatih Köse, Amanda L Jackson, Ingrid A Boere, Giovanni Scambia, Leslie M Randall, Azmat Sadozye, Jean-François Baurain, Eelke H Gort, Michal Zikán, Hannelore G Denys, Petronella B Ottevanger, Frédéric Forget, Camilla Mondrup Andreassen, Lamar Eaton, Michael J Chisamore, Leonardo Viana Nicacio, Ibrahima Soumaoro, Bradley J Monk
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Reply to Z.R. McCaw et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Bradley J Monk, Christine Parkinson, Myong Cheol Lim, David M O'Malley, Ana Oaknin, Michelle K Wilson, Robert L Coleman, Domenica Lorusso, Paul Bessette, Sharad Ghamande, Athina Christopoulou, Diane Provencher, Emily Prendergast, Fuat Demirkiran, Olga Mikheeva, Oladapo O Yeku, Anita Chudecka-Glaz, Michael Schenker, Ramey D Littell, Tamar Safra, Hung-Hsueh Chou, Mark A Morgan, Vít Drochýtek, Joyce N Barlin, Toon Van Gorp, Frederick Rand Ueland, Gabriel Lindahl, Charles Anderson, Dearbhaile C Collins, Kathleen M Moore, Frederic Marmé, Shannon Neville Westin, Iain A McNeish, Danny Shih, Kevin K Lin, Sandra Goble, Stephanie Hume, Keiichi Fujiwara, Rebecca S Kristeleit
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Elena Giudice, Vanda Salutari, Caterina Ricci, Camilla Nero, Maria Vittoria Carbone, Lucia Musacchio, Viola Ghizzoni, Maria Teresa Perri, Floriana Camarda, Francesca Tronconi, Domenica Lorusso, Giovanni Scambia
Recent progress in the use of pharmacotherapy for endometrial cancer. Expert opinion on pharmacotherapy (2022)
Panagiotis A Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, Michael L Friedlander, Rosalind M Glasspool, Domenica Lorusso, Christian Marth, Bradley J Monk, Jae-Weon Kim, Patsy Hinson, Olga Ajipa, Vincent Pretre, Yu Han, Ursula A Matulonis
EPIK-O/ENGOT-OV61: Alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study). Future oncology (London, England) (2022)
Camilla Nero, Francesca Tronconi, Elena Giudice, Giovanni Scambia, Domenica Lorusso
Management of stage III and IVa uterine cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 32 (3) (2022)
Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Domenica Lorusso, Anna Fagotti, Giovanni Scambia
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert opinion on investigational drugs 30 (2) (2021)
Andrew R Clamp, Domenica Lorusso, Amit M Oza, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O'Malley, Deborah K Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M Swisher, Terri Cameron, Sandra Goble, Robert L Coleman, Jonathan A Ledermann
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 31 (7) (2021)
Domenica Lorusso, Valentina Ceni, Gennaro Daniele, Antonella Pietragalla, Vanda Salutari, Margherita Muratore, Camilla Nero, Francesca Ciccarone, Giovanni Scambia
Immunotherapy in gynecological cancers. Exploration of targeted anti-tumor therapy 2 (1) (2021)
Antonella Pietragalla, Francesca Ciccarone, Camilla Nero, Giovanni Scambia, Domenica Lorusso, Gennaro Daniele
Integration of PARP-inhibitors in ovarian cancer therapy. Exploration of targeted anti-tumor therapy 1 (3) (2020)
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del Vecchio
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience. Journal of gynecologic oncology 30 (6) (2020)
Domenica Lorusso, Giuseppa Maltese, Ilaria Sabatucci, Sara Cresta, Cristina Matteo, Tommaso Ceruti, Maurizio D'Incalci, Massimo Zucchetti, Francesco Raspagliesi, Cristina Sonetto, Valentina Sinno, Dominique Ronzulli, Serena Giolitto, Filippo de Braud
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile. Targeted oncology 16 (1) (2020)
Giorgio Bogani, Diego Rossetti, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Chiara Leone, Umberto Leone Roberti Maggiore, Domenica Lorusso, Francesco Raspagliesi
Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery. Journal of gynecologic oncology 30 (2) (2018)
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Ilaria Sabatucci, Umberto Leone Roberti Maggiore, Domenica Lorusso, Francesco Raspagliesi
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses. Journal of gynecologic oncology 29 (3) (2018)
Giorgio Bogani, Diego Rossetti, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Umberto Leone Roberti Maggiore, Stefano Ferla, Domenica Lorusso, Francesco Raspagliesi
Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer. Journal of gynecologic oncology 29 (5) (2018)
Giorgio Bogani, Antonino Ditto, Stefano Ferla, Biagio Paolini, Claudia Lombardo, Domenica Lorusso, Francesco Raspagliesi
Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia. Journal of gynecologic oncology 30 (2) (2018)
Giorgio Bogani, Umberto Leone Roberti Maggiore, Biagio Paolini, Antonino Ditto, Fabio Martinelli, Domenica Lorusso, Francesco Raspagliesi
The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer. Journal of gynecologic oncology 30 (1) (2018)